FOXK2 and osteoporosis: Our results suggest that Foxk2 plays a key role in adipocyte differentiation in vitro, and that the Foxk2‐Pparγ axis may serve as a potential therapeutic target in the continuum of aging‐associated or oestrogen lose‐induced bone marrow adipose accumulation and osteoporosis.